** U.S.-listed shares of China-based internet medical and
health co YI.O up 7.97% at $19.5 premarket
** Co's Q4 rev. rose 96.1% to 2.64 bln yuan ($405.1 mln)
from a year earlier, aided by a 108.7% rise in its B2B segment
rev. urn:newsml:reuters.com:*:nPnpDVt3a
** YI posts Q4 adj. loss of 18 cents/ADS, compared with a
loss of 70 cents/ADS in the same qtr last year as general and
administrative expenses fell
** Co forecast Q1 rev. between 2.53 bln yuan and 2.6 bln
yuan, representing an year-over-year growth of ~61% to 65%, or
87% to 93%, excluding the impacts of pandemic related one-off
sales
** Shares up 159.9% for the year, as of last close
(Reporting by Devik Jain in Bengaluru)
((Devik.Jain@thomsonreuters.com; within U.S. +1 646 223 8780;
outside U.S. +91 80 6182 2062; ;))